AdvanSix Inc.

Listed Company

ASIXCIK 0001673985NYSELarge AcceleratedPlastic Materials, Synth Resins & Nonvulcan ElastomersDelawareFY ends Dec 31

Period

FY 2025

Revenue

—

Net Income

$49.29M

Total Assets

$1.71B

Equity

$815.22M

Shares Out

26.87M

Op. Cash Flow

$122.86M

Business

AdvanSix Inc. is a diversified chemistry company that manufactures and supplies integrated chemical products for a wide range of industrial and agricultural end markets. It offers Nylon 6 resin and caprolactam, ammonium sulfate fertilizer, and a portfolio of chemical intermediates including acetone, phenol, AMS, cyclohexanone, oximes and specialty amines. The business operates through three principal product lines—Nylon Solutions, Plant Nutrients and Chemical Intermediates—supported by five U.S.-based manufacturing sites. AdvanSix primarily serves customers in the United States with global sales capabilities, selling directly under contracts, by purchase order and through distributors.

Summary from filing dated 2025-02-21

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Sales	1,522	1,518	1,534	1,946	1,685
Cost of goods sold	1,357	1,365	1,369	1,631	1,411
Selling, general and administrative expenses	105	94	96	88	83
Interest expense, net	8	11	7	3	5
Other non-operating (income) expense, net	−3	2	−7	−2	998,000
Total costs, expenses and other	1,468	1,472	1,464	1,720	1,500
Income before taxes	54	46	69	226	185
Income tax expense	5	1	15	54	45
Net income	49	44	55	172	140
Basic (in dollars per share)	1.83	1.65	2	6.15	4.97
Diluted (in dollars per share)	1.8	1.62	1.95	5.92	4.81
Basic (in shares)	27	27	27	28	28
Diluted (in shares)	27	27	28	29	29

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	20	20	30	31	15
Accounts and other receivables net	154	146	165	175	178
Inventories net	236	212	212	216	150
Taxes receivable	22	503,000	1	10	947,000
Other current assets	9	9	11	9	6
Total current assets	441	387	420	441	350
Property, plant and equipment net	964	918	853	811	768
Operating lease right-of-use assets	164	153	96	115	136
Goodwill	56	56	56	56	18
Intangible assets	40	43	46	49	18
Other assets	41	37	25	23	22
Total assets	1,706	1,595	1,496	1,495	1,312
Accounts payable	284	229	259	273	221
Accrued liabilities	46	47	44	49	50
Operating lease liabilities short-term	44	42	32	37	36
Income taxes payable	1	1	8	30,000	—
Deferred income and customer advances	15	38	16	34	3
Total current liabilities	390	357	359	393	310
Deferred income taxes	154	145	151	160	133
Operating lease liabilities long-term	121	111	64	78	101
Line of credit long-term	215	195	170	115	135
Other liabilities	11	11	9	11	14
Total liabilities	891	820	757	757	711
COMMITMENTS AND CONTINGENCIES (Note 11)	—	—	—	—	—
Common stock, par value $0.01; 200,000,000 shares authorized; 33,177,824 shares issued and 26,864,035 outstanding at December 31, 2025; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024	332,000	330,000	326,000	320,000	318,000
Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2025 and 2024	0	0	0	0	0
Treasury stock at par (6,313,789 shares at December 31, 2025; 6,252,129 shares at December 31, 2024)	−63,000	−63,000	−58,000	−45,000	—
Additional paid-in capital	143	137	138	175	196
Retained earnings	663	632	605	568	412
Accumulated other comprehensive income	9	6	−4	−4	−7
Total stockholders' equity	815	775	739	738	601
Total liabilities and stockholders' equity	1,706	1,595	1,496	1,495	1,312

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	80	76	73	69	65
(Gain) loss on disposal of assets	−81,000	773,000	1	2	2
Deferred income taxes	8	−9	−9	16	5
Stock-based compensation	7	8	8	10	11
Amortization of deferred financing fees	597,000	618,000	618,000	618,000	677,000
Operational asset adjustments	0	1	−4	0	0
Accounts and other receivables	−8	18	21	18	−54
Inventories	−24	−555,000	3	−57	31
Taxes receivable	−21	931,000	8	−9	11
Accounts payable	53	−31	−21	56	16
Income taxes payable	53,000	−7	8	−10	10
Accrued liabilities	−808,000	2	−6	−3	15
Deferred income and customer advances	−23	22	−19	32	−24
Other assets and liabilities	3	8	−3	−23	−10
Net cash provided by operating activities	123	135	118	274	219
Expenditures for property, plant and equipment	−116	−134	−107	−89	−57
Other investing activities	−6	−9	−4	−2	−1
Net cash used for investing activities	−123	−143	−111	−189	−68
Borrowings from line of credit	371	406	437	435	176
Repayments of line of credit	−351	−381	−382	−455	−316
Payment of line of credit facility fees	−478,000	0	0	0	−2
Principal payments of finance leases	−1	−1	−938,000	−926,000	−735,000
Dividend payments	−17	−17	−17	−15	−4
Purchase of treasury stock	−2	−10	−46	−34	−652,000
Issuance of common stock	267,000	859,000	876,000	1	554,000
Net cash used for financing activities	−47,000	−3	−8	−68	−147
Net change in cash and cash equivalents	202,000	−10	−1	16	4
Capital expenditures included in accounts payable	27	24	23	15	12
Cash paid for interest	7	11	7	2	4
Cash paid for income taxes, net of refund	15	17	8	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro